Heart rate dependence of aortic pulse wave velocity at different arterial pressures in rats

Hypertension
Isabella TanAlberto Avolio

Abstract

Arterial stiffness, as measured by aortic pulse wave velocity (PWV), is an independent marker of cardiovascular disease and events in both healthy and diseased populations. Although some cardiovascular risk factors, such as age and blood pressure, show a strong association with PWV, the association between heart rate (HR) and PWV is not firmly established. Furthermore, this association has not been investigated at different arterial blood pressures. To study effects of HR on aortic PWV at different mean arterial pressures (MAPs), adult (12 weeks; n=7), male, anesthetized Sprague-Dawley rats were randomly paced at HRs of between 300 and 450 bpm, at 50-bpm steps. At each pacing step, aortic PWV was measured across a physiological MAP range of 60 to 150 mmHg by infusing sodium nitroprusside and phenylephrine. When compared at the same MAP, increases in HR resulted in significant increases in PWV at all of the MAPs >80 mmHg (ANOVA, P<0.05), with the greatest significant change of 6.03±0.93% observed in the range 110 to 130 mmHg. The positive significant association between HR and PWV remained when PWV was adjusted for MAP (ANOVA, P<0.001). These results indicate that HR dependency of PWV is different at higher pressures than at low...Continue Reading

References

Oct 1, 1979·British Journal of Pharmacology·B M Altura, J Weinberg
May 1, 1991·American Heart Journal·Y C ChiuJ D Carroll
Jun 1, 1987·American Heart Journal·W B KannelL A Cupples
Apr 1, 1986·European Heart Journal·L WilhelmsenL Werkö
Mar 1, 1967·Journal of Applied Physiology·W R Stahl
Feb 1, 1993·Journal of the American College of Cardiology·J A BreallW Grossman
Apr 1, 1993·American Heart Journal·M W GillmanR B D'Agostino
Jul 1, 1996·Journal of Hypertension·A A MangoniG Mancia
Nov 3, 1998·Cardiovascular Research·C StefanadisP Toutouzas
Apr 1, 1999·Journal of Hypertension·M F O'Rourke, G Mancia
May 4, 1999·Clinical and Experimental Pharmacology & Physiology·Y L LiangA M Dart
May 16, 2000·The Journal of Physiology·I B WilkinsonD J Webb
Apr 6, 2001·Journal of Hypertension·J AmarJ Ferrières
May 10, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Luyi SenBramah N Singh
Jun 8, 2002·Hypertension·Pierre LantelmeHugues Milon
Feb 25, 2003·Life Sciences·Robert L HamlinCynthia A Carnes
Mar 18, 2003·Journal of Hypertension·Michael F O'Rourke, Chris S Hayward
Aug 13, 2003·Hypertension·Cristina GiannattasioGiuseppe Mancia
Aug 18, 2004·Journal of Hypertension·Pierre AlbaladejoPatrick Lacolley
Jan 12, 2005·Hypertension·Sandrine C MillasseauPhilip J Chowienczyk
Feb 11, 2005·Clinical and Experimental Hypertension : CHE·P Palatini, S Julius
May 1, 1961·The Journal of Physiology·D H Bergel
Mar 12, 2008·Annals of Biomedical Engineering·Mariya L AntonovaLubomir N Kasakov
Apr 11, 2008·Physiological Measurement·Shuzhen ChenGangmin Ning
Nov 20, 2008·Journal of the American College of Cardiology·Sripal BangaloreFranz H Messerli
May 1, 2008·Journal of the American Society of Hypertension : JASH·Wei ChenGerald S Berenson

❮ Previous
Next ❯

Citations

Jan 7, 2014·Microvascular Research·S Mojtaba GolzanStuart L Graham
Aug 31, 2016·Nature Reviews. Nephrology·Panagiotis I Georgianos, Rajiv Agarwal
Jan 13, 2015·American Journal of Hypertension·Kazuo EguchiKazuomi Kario
Jun 19, 2017·Ultrasound in Medicine & Biology·Chin-Chia HuangChih-Chung Huang
Mar 23, 2018·Journal of Applied Physiology·Lutz E KraushaarAlexander Massmann
Apr 2, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Hanguang XiaoAlberto P Avolio
Jan 31, 2018·Journal of the American Heart Association·Massimo NardonePhilip J Millar
Jul 4, 2018·Hypertension·Kathryn SandbergJason G Umans
Jun 2, 2016·Hypertension·Isabella TanMark Butlin
Jul 15, 2015·Hypertension·Raymond R TownsendUNKNOWN American Heart Association Council on Hypertension
Mar 19, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Panagiotis I Georgianos, Rajiv Agarwal
Sep 14, 2013·American Journal of Hypertension·Huynh L QuanAlison J Venn
Aug 10, 2019·Research Quarterly for Exercise and Sport·Pascal BauerTill Keller
Sep 21, 2013·Journal of Applied Physiology·Paolo SalviAthanase Benetos
Jan 10, 2014·Science Translational Medicine·Nora LangPedro J del Nido
Apr 10, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Mark ButlinAlberto P Avolio
Nov 28, 2013·Journal of Hypertension·Pierre BoutouyrieUNKNOWN EXPLOR trialists
Apr 16, 2020·International Journal of Environmental Research and Public Health·Md Rizman Md Lazin Md LazimMohd Shawal Faizal Mohamad
May 14, 2020·International Journal of Molecular Sciences·Wenxi ZhangWenchang Tan
Mar 15, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Mark ButlinAlberto P Avolio
Mar 30, 2013·American Journal of Hypertension·Nancy K SweitzerGary F Mitchell
Oct 5, 2017·Heart and Vessels·Yurie ObataViachaslau Barodka
Nov 5, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Hanguang XiaoAlberto P Avolio
Dec 3, 2016·BioMed Research International·Yurie ObataViachaslau Barodka
Sep 25, 2017·Scientific Reports·Peter DungelAndrey V Kozlov
Nov 9, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Zhen WangFeng Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.